Concepedia

Ryan M. Reyes

RM

7

Publications

183

Citations

7

H-Index

2020

Active since

Affiliations

The University of Texas Health Science Center at San Antonio(Current)

The University of Texas at San Antonio

Mays Cancer Center at UT Health San Antonio

The University of Texas Health Science Center at Houston

Moffitt Cancer Center

Ryan M. Reyes is an author at The University of Texas Health Science Center at San Antonio specializing in cancer cell biology, tumor biology, and tumor immunity.

ORCID

Top concepts

Publications per year

2020–2023

7

Publications

7

Bladder cancer cell‐intrinsic PD‐L1 signals promote mTOR and autophagy activation that can be inhibited to improve cytotoxic chemotherapy

Deyi Zhang, Ryan M. Reyes, Erica Osta et al. · Cancer Medicine · 2021 · 44 citations · Full text

, , +21

CD122-Selective IL2 Complexes Reduce Immunosuppression, Promote Treg Fragility, and Sensitize Tumor Response to PD-L1 Blockade

Justin Drerup, Yilun Deng, Sri Lakshmi Pandeswara et al. · Cancer Research · 2020 · 33 citations · Full text

Rapamycin enhances BCG-specific γδ T cells during intravesical BCG therapy for non-muscle invasive bladder cancer: a randomized, double-blind study

Niannian Ji, Neelam Mukherjee, Ryan M. Reyes et al. · Journal for ImmunoTherapy of Cancer · 2021 · 28 citations · Full text

Immune checkpoint expression and relationships to anti‐PD‐L1 immune checkpoint blockade cancer immunotherapy efficacy in aged versus young mice

Myrna Garcia, Yilun Deng, Clare Murray et al. · Aging and Cancer · 2022 · 28 citations · Full text

CD122-directed interleukin-2 treatment mechanisms in bladder cancer differ from αPD-L1 and include tissue-selective γδ T cell activation

Ryan M. Reyes, Yilun Deng, Deyi Zhang et al. · Journal for ImmunoTherapy of Cancer · 2021 · 22 citations · Full text

Rows per page

1–5 of 7